NeoGenomics, Inc. Share-based Payment Arrangement, Accelerated Cost
NeoGenomics, Inc. (NEO) reported Share-based Payment Arrangement, Accelerated Cost of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2026-07-28
- NeoGenomics, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- NeoGenomics, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2026-03-31 was $400.00K.
- NeoGenomics, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-09-30 was $200.00K.
- NeoGenomics, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2025-06-30 was $2.60M, a 333.33% increase year-over-year.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-28 | $400.00K 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $400.00K 10-Q · filed 2026-04-28 | ||
| 2025-09-30 | $200.00K 10-Q · filed 2025-10-28 | $2.80M derived: sum of 2 quarters · filed 2026-07-28 | $2.80M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $2.60M 10-Q · filed 2026-07-28 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-10-28 | $600.00K derived: sum of 2 quarters · filed 2025-10-28 | $600.00K 10-Q · filed 2025-10-28 |
| 2024-06-30 | $600.00K 10-Q · filed 2025-07-29 | ||
| 2023-09-30 | $900.00K 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | $900.00K 10-Q · filed 2024-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |